Abstract
A 29-year-old male was diagnosed with ileocolic Crohn’s disease (CD) approximately 2 years ago. Adalimumab was prescribed as CD remission induction therapy. Three months after beginning adalimumab, watery diarrhea and lower abdominal pain developed. He was admitted under a diagnosis of CD exacerbation. Despite fasting and antibiotic treatment, symptoms of acute panperitonitis appeared. He was diagnosed as acute appendicitis and we performed emergency surgery for peritoneal drainage and ileocecal resection on the fifth hospital day. We diagnosed periappendicitis based on the operative findings. This is the first report of periappendicitis with CD during adalimumab treatment.
Similar content being viewed by others
References
Abraham C, Cho JH. Inflammatory bowel disease. Engl J Med. 2009;361:2066–78.
Colombel JF, Rutgeerts PJ, Sandborn WJ, et al. Adalimumab induces deep remission in patients with Crohn’s disease. Clin Gastroenterol Hepatol. 2014;12(414–22):e5.
Mandel MD, Miheller P, Mullner K, et al. Have biologics changed the natural history of Crohn’s disease? Dig Dis (Basel Switz). 2014;32:351–9.
Watanabe M, Hibi T, Mostafa NM, et al. Long-term safety and efficacy of adalimumab in Japanese patients with moderate to severe Crohn’s disease. J Crohn’s Colitis 2014.
Fink AS, Kosakowski CA, Hiatt JR, Cochran AJ. Periappendicitis is a significant clinical finding. Am J Surg. 1990;159:564–8.
Chaudhary P, Nabi I, Arora MP. Periappendicitis: our 13 year experience. Int J Surg (Lond Engl). 2014;12:1010–3.
O’Neil MB, Moore DB. Periappendicitis: clinical reality or pathologic curiosity? Am J Surg. 1977;134:356–7.
Mukherjee A, Schlenker E, LaMasters T, et al. Periappendicitis: is it a clinical entity? Am Surg. 2002;68:913–6.
Savarino E, Bodini G, Dulbecco P, et al. Adalimumab is more effective than azathioprine and mesalamine at preventing postoperative recurrence of Crohn’s disease: a randomized controlled trial. Am J Gastroenterol. 2013;108:1731–42.
Syed A, Cross RK, Flasar MH. Anti-tumor necrosis factor therapy is associated with infections after abdominal surgery in Crohn’s disease patients. Am J Gastroenterol. 2013;108:583–93.
Disclosures
Conflict of Interest: All authors declare that they have no conflict of interest.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Mizuno, S., Nakazawa, A., Ogawa, A. et al. Periappendicitis during adalimumab treatment for ileocecal Crohn’s disease in a 29-year-old male. Clin J Gastroenterol 8, 134–137 (2015). https://doi.org/10.1007/s12328-015-0575-x
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12328-015-0575-x